Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSEtm Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Both studies involve a technology called pulse field ablation. Medtronic developed one version of the technology, and Farapulse, which is now owned by Boston Scientific, developed another.
Vice President, Head of Investor Relations
Good morning and welcome to Medtronic s Fiscal Year 2021 Third Quarter Earnings Video Webcast. I m Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
Before we start the prepared remarks, I m going to share with you a few details to keep in mind about today s webcast. Joining me today are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our third quarter, which ended on January 29, 2021. After our prepared remarks, we ll take questions from the sell-side analysts that cover the Company, and today s event should last about an hour.